APLI and APLIF Related Headlines

Go Back

Mar 30, 2026 07:19AM Appili Therapeutics to Exhibit at World Vaccine Congress Washington
Feb 18, 2026 07:19AM Appili Therapeutics closes C$100,000 private placement second tranche
Feb 18, 2026 07:19AM Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement
Feb 12, 2026 06:15PM Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
Dec 18, 2025 07:31AM Appili Therapeutics raises C$177,500 in first tranche of private placement
Dec 18, 2025 07:31AM Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement
Nov 13, 2025 05:21PM Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026
Nov 5, 2025 07:16AM Appili Therapeutics announces C$750,000 private placement
Nov 5, 2025 07:16AM Appili Therapeutics Announces Proposed Non-Brokered Private Placement
Oct 22, 2025 07:20AM Appili Therapeutics to Attend BARDA Innovation Symposium 2025
Oct 1, 2025 07:17AM NIAID awards Appili and Vitalex up to $40M for fungal vaccine development
Oct 1, 2025 07:17AM Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01
Sep 23, 2025 05:02PM Appili Therapeutics shareholders elect six directors at annual meeting
Sep 23, 2025 05:01PM Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
Sep 9, 2025 07:20AM Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference
Aug 14, 2025 05:05PM Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2026
Aug 6, 2025 07:21AM Appili Therapeutics and Colleagues Publish Manuscript Demonstrating Efficacy of ATI-1701 Tularemia Vaccine
Jun 25, 2025 06:04PM Appili Therapeutics Reports Fiscal Year 2025 Financial and Operational Results

APLI and APLIF Related Press Releases

Go Back

Mar 30, 2026 07:19AM Appili Therapeutics to Exhibit at World Vaccine Congress Washington
Feb 18, 2026 07:19AM Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement
Feb 12, 2026 06:15PM Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
Dec 18, 2025 07:31AM Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement
Nov 13, 2025 05:21PM Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026
Nov 5, 2025 07:16AM Appili Therapeutics Announces Proposed Non-Brokered Private Placement
Oct 22, 2025 07:20AM Appili Therapeutics to Attend BARDA Innovation Symposium 2025
Oct 1, 2025 07:17AM Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01
Sep 23, 2025 05:01PM Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
Sep 9, 2025 07:20AM Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference
Aug 14, 2025 05:05PM Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2026
Aug 6, 2025 07:21AM Appili Therapeutics and Colleagues Publish Manuscript Demonstrating Efficacy of ATI-1701 Tularemia Vaccine
Jun 25, 2025 06:04PM Appili Therapeutics Reports Fiscal Year 2025 Financial and Operational Results

APLI and APLIF Related SEC Filings

Go Back